Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 11/20 | 0.65 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.43 |
| ▸ | MAOB | P27338 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | HRH1 | P35367 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10226325 | 1.00 | HRH3 (0.65) | HRH3CXCR4SIGMAR1MAOBMAPT | |
| SCHEMBL13293933 | 1.00 | HRH3 (0.65) | HRH3CXCR4SIGMAR1MAOBMAPT | |
| SCHEMBL17523784 | 1.00 | HRH3 (0.65) | HRH3CXCR4SIGMAR1MAOBMAPT | |
| SCHEMBL17523768 | 1.00 | HRH3 (0.65) | HRH3CXCR4SIGMAR1MAOBMAPT | |
| SCHEMBL10032114 | 0.98 | HRH3 (0.61) | HRH3CXCR4SIGMAR1MAOBMAPT | |
| SCHEMBL13293936 | 0.98 | HRH3 (0.61) | HRH3CXCR4SIGMAR1MAOBMAPT | |
| SCHEMBL17523782 | 0.98 | HRH3 (0.61) | HRH3CXCR4SIGMAR1MAOBMAPT | |
| SCHEMBL13602667 | 0.98 | HRH3 (0.61) | HRH3CXCR4SIGMAR1MAOBMAPT | |
| SCHEMBL17523767 | 0.98 | HRH3 (0.61) | HRH3CXCR4SIGMAR1MAOBMAPT | |
| SCHEMBL13293934 | 0.98 | HRH3 (0.61) | HRH3CXCR4SIGMAR1MAOBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117222414-A | Compounds for activating constant natural killer T-cells and methods for eliminating inflammatory senescent cells | 脱落性治疗公司 | 2023-12-12 | — | — | CN | disclosed |